Anifrolumab reduces steroids in LTE
Leonard Calabrese
Share Talk
vumedi.com
to learn more
July 2, 2024
11 hr
Default user image
Log in Sign Up
Channels
DiscoveryAllergy
AAAAI 2026
Cardiology
Every Day
Dermatology
Every DayDerm-it Trotter! Don’t Swear About SkincareDerms on Drugs
Endocrinology
Thyroid TalkEvery DayATA 2022ENDO 2022
Gastroenterology
IBSEvery Day
Hematology
CLLEvery DayIMF Patient & FamilyMiracles For MyelomaASH 2024
Hepatology
Every Day
Infectious Disease
COVIDHIV
Nephrology
CKDEvery DayChannel Your EnthusiasmFreely FilteredASN 2024NKF SCM 22Kidney Week 2022
Neurology
GSA 2025
Oncology
Clinical TrialseBCGastrointestinalEvery DayHER2+ @ ASCO 2025ESMO 2022
Ophthalmology
Every DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyVISIONS 2024ARVO 2024AAO 2023WIO 2022
Primary Care
Every Day
Pulmonology
Every Day
Rheumatology
Every DayACR 2024
Urology
Every Day
Speaker

Description

Anifrolumab reduces steroids in LTE
Talk's display image
Anifrolumab reduces steroids in LTE